Targeted magnetic nanoparticles for mechanical lysis of tumor cells by low-amplitude alternating magnetic field

29Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.

Abstract

Currently available cancer therapies can cause damage to healthy tissue. We developed a unique method for specific mechanical lysis of cancer cells using superparamagnetic iron oxide nanoparticle rotation under a weak alternating magnetic field. Iron oxide core nanoparticles were coated with cetuximab, an anti-epidermal growth factor receptor antibody, for specific tumor targeting. Nude mice bearing a head and neck tumor were treated with cetuximab-coated magnetic nanoparticles (MNPs) and then received a 30 min treatment with a weak external alternating magnetic field (4 Hz) applied on alternating days (total of seven treatments, over 14 days). This treatment, compared to a pure antibody, exhibited a superior cell death effect over time. Furthermore, necrosis in the tumor site was detected by magnetic resonance (MR) images. Thermal camera images of head and neck squamous cell carcinoma cultures demonstrated that cell death occurred purely by a mechanical mechanism.

Cite

CITATION STYLE

APA

Vegerhof, A., Barnoy, E. A., Motiei, M., Malka, D., Danan, Y., Zalevsky, Z., & Popovtzer, R. (2016). Targeted magnetic nanoparticles for mechanical lysis of tumor cells by low-amplitude alternating magnetic field. Materials, 9(11). https://doi.org/10.3390/ma9110943

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free